The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Singulair Paediatric 4 mg chewable tablets

4 milligram(s) Chewable tablet

PCO Manufacturing Ltd.PPA0465/111/003

Main Information

Trade NameSingulair Paediatric 4 mg chewable tablets
Active SubstancesMontelukast
Strength4 milligram(s)
Dosage FormChewable tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/111/003

Group Information

ATC CodeR03DC Leukotriene receptor antagonists
R03DC03 montelukast

Status

Authorised/WithdrawnAuthorised
Licence Issued17/08/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA1286/046/001.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0023-008-007
Interchangeable List DocumentPDF of Interchangeable List
« Back